Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Immunobiology

Procalcitonin and C-reactive protein do not discriminate between febrile reaction to anti-T-lymphocyte antibodies and Gram-negative sepsis

Summary:

Treatment with antibodies against T-lymphocytes usually triggers a febrile response potentially mimicking or masking infection. Procalcitonin (PCT) is considered a sensitive and specific marker of systemic bacterial and fungal infection. It was the aim of this study to investigate the characteristics of PCT and C-reactive protein (CRP) during treatment with polyclonal or monoclonal anti-T-cell antibodies, in order to examine the ability of these parameters to distinguish between systemic bacterial infection and reaction to antibody treatment. Thus, 15 consecutive febrile episodes after T-cell antibody infusion without clinical signs of infection were compared with nine episodes of Gram-negative sepsis. After T-cell antibody infusion PCT and CRP serum levels increased to a similar extent as in Gram-negative sepsis. Therefore, during T-cell antibody treatment neither PCT nor CRP are adequate for differentiating between fever due to infection or to unspecific cytokine release.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Dearden C, Foukaneli T, Lee P et al. The incidence and significance of fevers during treatment with antithymocyte globulin for aplastic anaemia. Br J Haematol 1998; 103: 846–848.

    Article  CAS  Google Scholar 

  2. Peltola H, Jaakkola M . C-reactive protein in early detection of bacteremic versus viral infections in immunocompetent and compromised children. J Pediatr 1988; 113: 641–646.

    Article  CAS  Google Scholar 

  3. Legouffe E, Rodriguez C, Picot MC et al. C-reactive protein serum level is a valuable and simple prognostic marker in non Hodgkin's lymphoma. Leukemia Lymphoma 1998; 31: 351–357.

    Article  CAS  Google Scholar 

  4. Dornbusch HJ, Kerbl R, Lackner H et al. Procalcitonin and C-reactive protein levels at the time of engraftment after stem cell transplantation. Acta Chir Austr 2000; 32: 37 (abstract P38).

    Google Scholar 

  5. Assicot M, Gendrel D, Carsin H et al. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993; 341: 515–518.

    Article  CAS  Google Scholar 

  6. Fleischhack G, Kambeck I, Cipic D et al. Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin-6, interleukin-8, soluble interleukin-2 receptor and soluble tumour necrosis factor receptor II. Br J Haematol 2000; 111: 1093–1102.

    Article  CAS  Google Scholar 

  7. Nijsten MW, Olinga P, The TH et al. Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit Care Med 2000; 28: 458–461.

    Article  CAS  Google Scholar 

  8. Lacour AG, Gervaix A, Zamora SA et al. Procalcitonin, IL-6, IL-8, IL-1 receptor antagonist and C-reactive protein as identificators of serious bacterial infections in children with fever without localising signs. Eur J Pediatr 2001; 160: 95–100.

    Article  CAS  Google Scholar 

  9. Kuse ER, Jaeger K . Procalcitonin increase after anti-CD3 monoclonal antibody therapy does not indicate infectious disease. Transplant Int 2001; 14: 55 (letter).

    Article  CAS  Google Scholar 

  10. Sabat R, Hoflich C, Docke WD et al. Massive elevation of procalcitonin plasma levels in the absence of infection in kidney transplant patients treated with pan-T-cell antibodies. Intens Care Med 2001; 27: 987–991.

    Article  CAS  Google Scholar 

  11. Eberhard OK, Langefeld I, Kuse ER et al. Procalcitonin in the early phase after renal transplantation – will it add to diagnostic accuracy? Clin Transplant 1998; 12: 206–211.

    CAS  PubMed  Google Scholar 

  12. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864–874.

  13. Hayden WR . Sepsis terminology in pediatrics. J Pediatr 1994; 124: 657–658.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We are indebted to Andrea Berghold and Petra Ofner from the Institute for Medical Informatics, Statistics and Documentation for their professional assistance in statistical analysis.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H J Dornbusch.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dornbusch, H., Strenger, V., Kerbl, R. et al. Procalcitonin and C-reactive protein do not discriminate between febrile reaction to anti-T-lymphocyte antibodies and Gram-negative sepsis. Bone Marrow Transplant 32, 941–945 (2003). https://doi.org/10.1038/sj.bmt.1704265

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704265

Keywords

This article is cited by

Search

Quick links